AMWL
American Well Corporation - Ordinary Shares - Class A

3,546
Mkt Cap
$78.58M
Volume
99,656.00
52W High
$12.95
52W Low
$3.71
PE Ratio
-0.68
AMWL Fundamentals
Price
$4.91
Prev Close
$4.80
Open
$4.78
50D MA
$4.50
Beta
1.60
Avg. Volume
135,458.89
EPS (Annual)
-$13.88
P/B
0.31
Rev/Employee
$290,038.77
Loading...
Loading...
News
all
press releases
Hims & Hers Expands Subscription-Led Care as Platform Engagement Grows
HIMS deepens its subscription-led model with new care verticals, diagnostics and global expansion to boost retention.
Zacks·9d ago
News Placeholder
More News
News Placeholder
We're still talking about the Trump phone
Every week at The Verge, we're tracking what's happening with Trump Mobile's promised and yet undelivered Android phone. Why? Because we cover phones. We also cover vaporware, which the T1 Phone 8002...
The Verge·20d ago
News Placeholder
American Well Corporation (NYSE:AMWL) Given Average Recommendation of "Hold" by Analysts
Shares of American Well Corporation (NYSE:AMWL - Get Free Report) have received a consensus recommendation of "Hold" from the eight brokerages that are covering the firm, Marketbeat reports. One...
MarketBeat·21d ago
News Placeholder
American Well (NYSE:AMWL) Insider Phyllis Gotlib Sells 3,574 Shares
American Well Corporation (NYSE:AMWL - Get Free Report) insider Phyllis Gotlib sold 3,574 shares of American Well stock in a transaction that occurred on Monday, December 1st. The shares were sold at...
MarketBeat·27d ago
News Placeholder
American Well (NYSE:AMWL) Insider Sells $14,510.44 in Stock
American Well Corporation (NYSE:AMWL - Get Free Report) insider Phyllis Gotlib sold 3,574 shares of the stock in a transaction that occurred on Monday, December 1st. The stock was sold at an average...
MarketBeat·28d ago
News Placeholder
Hims & Hers Expands Care Scope as Prescription Platforms Evolve
HIMS grows its telehealth-to-prescription model with new offerings in weight loss, hormone care and diagnostics.
Zacks·29d ago
News Placeholder
Hims & Hers Plunges 15.6% in 3 Months: Time to Hold the Stock or Sell?
HIMS faces rising regulatory strain, margin pressure and competition despite strong revenue momentum.
Zacks·1mo ago
News Placeholder
Hims & Hers Scales Technology-Enabled, Vertically Integrated Care
HIMS deepens its technology-enabled care model with new offerings in GLP-1 weight loss, hormone health, and custom treatments.
Zacks·2mo ago
News Placeholder
Wells Fargo & Company Issues Pessimistic Forecast for American Well (NYSE:AMWL) Stock Price
Wells Fargo & Company reduced their price objective on American Well from $12.00 to $9.00 and set an "overweight" rating for the company in a research note on Wednesday...
MarketBeat·2mo ago
News Placeholder
American Well (NYSE:AMWL) Given New $6.00 Price Target at Stifel Nicolaus
Stifel Nicolaus dropped their price target on American Well from $8.00 to $6.00 and set a "hold" rating on the stock in a research report on Wednesday...
MarketBeat·2mo ago
<
1
2
...
>

Latest AMWL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.